Titin truncating variants in dilated cardiomyopathy - Prevalence and genotype-phenotype correlations

PLoS ONE

Volumn 12, Issue 1, 2017, Pages

  Franaszczyk, Maria ^a   Chmielewski, Przemyslaw ^a   Truszkowska, Grazyna ^a   Stawinski, Piotr ^b   Michalak, Ewa ^a   Rydzanicz, Malgorzata ^c   Sobieszczanska Malek, Malgorzata ^a   Pollak, Agnieszka ^b   Szczygieł, Justyna ^a   Kosinska, Joanna ^c   Parulski, Adam ^a   Stoklosa, Tomasz ^d   Tarnowska, Agnieszka ^a   Machnicki, Marcin M ^c,d   Foss Nieradko, Bogna ^a   Szperl, Malgorzata ^a   Sioma, Agnieszka ^a   Kusmierczyk, Mariusz ^a   Grzybowski, Jacek ^a   Zielinski, Tomasz ^a   Ploski, Rafal ^c   Bilinska, Zofia T ^a   more..

^a INSTITUTE OF CARDIOLOGY   (Poland)

^b INSTITUTE OF PHYSIOLOGY AND PATHOLOGY OF HEARING   (Poland)

^c MEDICAL UNIVERSITY OF WARSAW   (Poland)

^d MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CONNECTIN; MESSENGER RNA;

ADULT; ADVERSE OUTCOME; ARTICLE; BLOOD SAMPLING; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DNA DETERMINATION; FAMILY HISTORY; FEMALE; GENE FREQUENCY; GENE SEGREGATION; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; GENOTYPE PHENOTYPE CORRELATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; NEXT GENERATION SEQUENCING; PREVALENCE; PROGNOSIS; SEX DIFFERENCE; SURVIVAL RATE; TTN GENE; COHORT ANALYSIS; GENETIC ASSOCIATION STUDY; GENETICS; HETEROZYGOTE; KAPLAN MEIER METHOD; METABOLISM; MUTATION; PENETRANCE;

ADULT; CARDIOMYOPATHY, DILATED; COHORT STUDIES; CONNECTIN; FEMALE; GENETIC ASSOCIATION STUDIES; HETEROZYGOTE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MUTATION; PENETRANCE; PREVALENCE; RNA, MESSENGER;

EID: 85008213299     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0169007     Document Type: Article

References (23)

1. Hershberger RE, Hedges DJ, Morales A. Dilated cardiomyopathy: the complexity of a diverse genetic architecture. Nature reviews Cardiology. 2013; 10(9):531-47. doi: 10.1038/nrcardio.2013.105 PMID: 23900355
2. Herman DS, Lam L, Taylor MR, Wang L, Teekakirikul P, Christodoulou D, et al. Truncations of titin causing dilated cardiomyopathy. The New England journal of medicine. 2012; 366(7):619-28. PubMed Central PMCID: PMC3660031. doi: 10.1056/NEJMoa1110186 PMID: 22335739
3. Akinrinade O, Ollila L, Vattulainen S, Tallila J, Gentile M, Salmenpera P, et al. Genetics and genotype-phenotype correlations in Finnish patients with dilated cardiomyopathy. European heart journal. 2015; 36(34):2327-37. PubMed Central PMCID: PMC4561350. doi: 10.1093/eurheartj/ehv253 PMID: 26084686
4. Morales A, Hershberger RE. The Rationale and Timing of Molecular Genetic Testing for Dilated Cardiomyopathy. The Canadian journal of cardiology. 2015; 31(11):1309-12. doi: 10.1016/j.cjca.2015.06.034 PMID: 26518443
5. Haas J, Frese KS, Peil B, Kloos W, Keller A, Nietsch R, et al. Atlas of the clinical genetics of human dilated cardiomyopathy. European heart journal. 2015; 36(18):1123-35a. doi: 10.1093/eurheartj/ehu301 PMID: 25163546
6. Roberts AM, Ware JS, Herman DS, Schafer S, Baksi J, Bick AG, et al. Integrated allelic, transcriptional, and phenomic dissection of the cardiac effects of titin truncations in health and disease. Science translational medicine. 2015; 7(270):270ra6. PubMed Central PMCID: PMC4560092. doi: 10.1126/scitranslmed.3010134 PMID: 25589632
7. Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P, et al. Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. European heart journal. 2008; 29(2):270-6. doi: 10.1093/eurheartj/ehm342 PMID: 17916581
8. Pinto YM, Elliott PM, Arbustini E, Adler Y, Anastasakis A, Böhm M, et al. Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases. Eur Heart J. 2016; 37(23):1850-8. Epub 2016/01/19. doi: 10.1093/eurheartj/ehv727 PMID: 26792875
9. Henry WL, Gardin JM, Ware JH. Echocardiographic measurements in normal subjects from infancy to old age. Circulation. 1980; 62(5):1054-61. PMID: 7418156
10. Ploski R, Pollak A, Muller S, Franaszczyk M, Michalak E, Kosinska J, et al. Does p.Q247X in TRIM63 cause human hypertrophic cardiomyopathy? Circulation research. 2014; 114(2):e2-5. doi: 10.1161/CIRCRESAHA.114.302662 PMID: 24436435
11. Akinrinade O, Koskenvuo JW, Alastalo TP. Prevalence of Titin Truncating Variants in General Population. PLoS One. 2015; 10(12):e0145284. PubMed Central PMCID: PMCPMC4689403. doi: 10.1371/journal.pone.0145284 PMID: 26701604
12. Hershberger RE, Parks SB, Kushner JD, Li D, Ludwigsen S, Jakobs P, et al. Coding sequence mutations identified in MYH7, TNNT2, SCN5A, CSRP3, LBD3, and TCAP from 313 patients with familial or idiopathic dilated cardiomyopathy. Clin Transl Sci. 2008; 1(1):21-6. PubMed Central PMCID: PMCPMC2633921. doi: 10.1111/j.1752-8062.2008.00017.x PMID: 19412328
13. Cox MG, van der Zwaag PA, van der Werf C, van der Smagt JJ, Noorman M, Bhuiyan ZA, et al. Arrhythmogenic right ventricular dysplasia/cardiomyopathy: pathogenic desmosome mutations in index-patients predict outcome of family screening: Dutch arrhythmogenic right ventricular dysplasia/cardiomyopathy genotype-phenotype follow-up study. Circulation. 2011; 123(23):2690-700. doi: 10.1161/CIRCULATIONAHA.110.988287 PMID: 21606396
14. Gerull B, Gramlich M, Atherton J, McNabb M, Trombitas K, Sasse-Klaassen S, et al. Mutations of TTN, encoding the giant muscle filament titin, cause familial dilated cardiomyopathy. Nature genetics. 2002; 30(2):201-4. doi: 10.1038/ng815 PMID: 11788824
15. Pugh TJ, Kelly MA, Gowrisankar S, Hynes E, Seidman MA, Baxter SM, et al. The landscape of genetic variation in dilated cardiomyopathy as surveyed by clinical DNA sequencing. Genetics in medicine: official journal of the American College of Medical Genetics. 2014; 16(8):601-8.
16. Granzier HL, Labeit S. The giant protein titin: a major player in myocardial mechanics, signaling, and disease. Circulation research. 2004; 94(3):284-95. doi: 10.1161/01.RES.0000117769.88862.F8 PMID: 14976139
17. Itoh-Satoh M, Hayashi T, Nishi H, Koga Y, Arimura T, Koyanagi T, et al. Titin mutations as the molecular basis for dilated cardiomyopathy. Biochemical and biophysical research communications. 2002; 291 (2):385-93. doi: 10.1006/bbrc.2002.6448 PMID: 11846417
18. Jansweijer JA, Nieuwhof K, Russo F, Hoorntje ET, Jongbloed JD, Lekanne Deprez RH, et al. Truncating titin mutations are associated with a mild and treatable form of dilated cardiomyopathy. Eur J Heart Fail. 2016.
19. Cheng WC, Shu WY, Li CY, Tsai ML, Chang CW, Chen CR, et al. Intra- and inter-individual variance of gene expression in clinical studies. PloS one. 2012; 7(6):e38650. PubMed Central PMCID: PMC3377725. doi: 10.1371/journal.pone.0038650 PMID: 22723873
20. Page SP, Kounas S, Syrris P, Christiansen M, Frank-Hansen R, Andersen PS, et al. Cardiac myosin binding protein-C mutations in families with hypertrophic cardiomyopathy: disease expression in relation to age, gender, and long term outcome. Circulation Cardiovascular genetics. 2012; 5(2):156-66. doi: 10.1161/CIRCGENETICS.111.960831 PMID: 22267749
21. Vytopil M, Ricci E, Dello Russo A, Hanisch F, Neudecker S, Zierz S, et al. Frequent low penetrance mutations in the Lamin A/C gene, causing Emery Dreifuss muscular dystrophy. Neuromuscular disorders: NMD. 2002; 12(10):958-63. PMID: 12467752
22. Taylor MR, Fain PR, Sinagra G, Robinson ML, Robertson AD, Carniel E, et al. Natural history of dilated cardiomyopathy due to lamin A/C gene mutations. Journal of the American College of Cardiology. 2003; 41(5):771-80. PMID: 12628721
23. Beckendorf L, Linke WA. Emerging importance of oxidative stress in regulating striated muscle elasticity. Journal of muscle research and cell motility. 2015; 36(1):25-36. PubMed Central PMCID: PMC4352196. doi: 10.1007/s10974-014-9392-y PMID: 25373878